132 related articles for article (PubMed ID: 7567317)
1. Pharmacokinetics of ceftibuten in children.
Barr WH; Affrime M; Lin CC; Batra V
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S93-101. PubMed ID: 7567317
[TBL] [Abstract][Full Text] [Related]
2. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
Kearns GL; Young RA
Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281
[TBL] [Abstract][Full Text] [Related]
3. Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
Kearns GL; Reed MD; Jacobs RF; Ardite M; Yogev RD; Blumer JL
Antimicrob Agents Chemother; 1991 Oct; 35(10):2078-84. PubMed ID: 1759830
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of ceftibuten in capsule and suspension forms.
Lin CC; Affrime M; Radwanski E; Lim J; Colucci R; Cayen MN
Clin Ther; 1996; 18(6):1139-49. PubMed ID: 9001830
[TBL] [Abstract][Full Text] [Related]
5. Penetration of ceftibuten into middle ear fluid.
Lin C; Kumari P; Perrotta RJ; Reidenberg BE
Antimicrob Agents Chemother; 1996 Jun; 40(6):1394-6. PubMed ID: 8726007
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of ceftibuten in humans.
Barr WH; Lin CC; Radwanski E; Lim J; Symchowicz S; Affrime M
Diagn Microbiol Infect Dis; 1991; 14(1):93-100. PubMed ID: 2013216
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and dose proportionality of ceftibuten in men.
Lin C; Lim J; Radwanski E; Marco A; Affrime M
Antimicrob Agents Chemother; 1995 Feb; 39(2):359-61. PubMed ID: 7726498
[TBL] [Abstract][Full Text] [Related]
8. Worldwide safety experience with ceftibuten pediatric suspension.
Reidenberg BE
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S130-3. PubMed ID: 7567313
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
Bressolle F; Galtier M; Kinowski JM; Goncalves F; Edno L; Panis R; Gomeni R
J Pharm Sci; 1994 Sep; 83(9):1236-40. PubMed ID: 7830237
[TBL] [Abstract][Full Text] [Related]
10. Ceftibuten: a new expanded-spectrum oral cephalosporin.
Guay DR
Ann Pharmacother; 1997 Sep; 31(9):1022-33. PubMed ID: 9296244
[TBL] [Abstract][Full Text] [Related]
11. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers.
Lin C; Radwanski E; Affrime M; Cayen MN
Antimicrob Agents Chemother; 1995 Feb; 39(2):356-8. PubMed ID: 7726497
[TBL] [Abstract][Full Text] [Related]
13. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Blumer JL; Mclinn SE; Deabate CA; Kafetzis DA; Perrotta RJ; Salgado O
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S115-20. PubMed ID: 7567311
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media.
Blumer JL; Forti WP; Summerhouse TL
Clin Ther; 1996; 18(5):811-20. PubMed ID: 8930425
[TBL] [Abstract][Full Text] [Related]
16. Failure of ceftibuten to alter single dose theophylline clearance.
Bachmann K; Schwartz J; Jauregui L; Martin M; Nunlee M
J Clin Pharmacol; 1990 May; 30(5):444-8. PubMed ID: 2347955
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency.
Kelloway JS; Awni WM; Lin CC; Lim J; Affrime MB; Keane WF; Matzke GR; Halstenson CE
Antimicrob Agents Chemother; 1991 Nov; 35(11):2267-74. PubMed ID: 1803999
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile of loracarbef.
DeSante KA; Zeckel ML
Am J Med; 1992 Jun; 92(6A):16S-19S. PubMed ID: 1621740
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
[TBL] [Abstract][Full Text] [Related]
20. Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Scaglione F; Demartini G; Dugnani S; Arcidiacono MM; Pintucci JP; Fraschini F
Br J Clin Pharmacol; 1999 Mar; 47(3):267-71. PubMed ID: 10215750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
